RemedyRepack Inc.: Drug Recall

Recall #D-0502-2023 · 03/20/2023

Class II: Risk

Recall Details

Recall Number
D-0502-2023
Classification
Class II
Product Type
Drug
Recalling Firm
RemedyRepack Inc.
Status
Terminated
Date Initiated
03/20/2023
Location
Indiana, PA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 76 bottles, b)151 bottles

Reason for Recall

cGMP Deviations

Product Description

Rosuvastatin 40mg tablets, packaged in a) 45-count bottles (NDC 70518-1311-01), and b) 90-count bottles (NDC 70518-0484-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Distribution Pattern

RemedyRepack distributed product to consignees nationwide within the United States

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.